A Practical Guide to Peritoneal Malignancy

The PMI Manual
1. Auflage 2019
ISBN: 978-1-138-49511-1
Verlag: CRC Press

Buch, Englisch, 214 Seiten, Format (B × H): 189 mm x 246 mm, Gewicht: 462 g

Peritoneal malignancy is a rapidly growing field within surgical oncology. National and International treatment programmes and training curricula are being established worldwide to co-ordinate treatment and management of these challenging clinical problems. A large body of evidence now exists, but the practical implications of this evidence base remain unclear. The Peritoneal Malignancy Institute in Basingstoke, the largest centre in the world, is at the forefront of new developments and techniques. This manual combines the experience of the PMI with the latest evidence to provide a practice-oriented guide to the successful set up and running of a peritoneal malignancy unit.

Zielgruppe

Professional Practice & Development

Autoren/Hrsg.

Cecil, Tom

Bunni, John

Mehta, Akash

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Chirurgie

Inhaltsverzeichnis

SET: UNDERSTANDING AND ASSESSMENT OF PERITONEAL DISEASE. Appendix tumours and pseudomyxoma peritonei: A ‘paradigm’ for peritoneal disease. Colorectal peritoneal metastases. Peritoneal mesothelioma. Miscellaneous peritoneal malignancies. Quantitative assessment of peritoneal disease. Imaging in peritoneal malignancy. DIALOGUE: INTRAPERITONEAL CHEMOTHERAPY AND CYTOREDUCTIVE SURGERY. Intraperitoneal chemotherapy. Perioperative and anaesthetic care. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Postoperative care. Postoperative complications. CLOSURE: ONGOING CARE AND FUTURE MANAGEMENT OPTIONS. Histopathological aspects of peritoneal malignancy. Follow-up protocols in peritoneal malignancy. Recurrence of pseudomyxoma peritonei. Future perspectives in peritoneal malignancy.

Über Autor(innen)

Tom Cecil is Clinical Director at the Peritoneal Malignancy Institute, Basingstoke, Hampshire Hospitals NHS Foundation Trust and Honorary Transplant Surgeon, Oxford University Hospitals, Oxford, UK.

John Bunni is a Consultant Colorectal and General Surgeon, Royal United Hospital, Bath, UK. He is also Visiting Lecturer, University of Bath, UK; Honorary Lecturer, Cardiff University, UK and was awarded the ASGBI Gold Medal.

Akash Mehta is Consultant Colorectal Surgeon at St Mark’s Hospital & Academic Institute, London, UK and holds the ESSO European Certification in Peritoneal Surface Oncology.